The World Anti-Doping Agency (WADA) has released its latest edition of ‘Spotlight’, which keeps stakeholders up to date on the activities being carried out by the World Anti-Doping Agency (WADA) team and its partners.
This edition looks at the Therapeutic Use Exemption (TUE) program. This program provides a harmonized global approach for athletes that have illnesses or medical conditions that require them to take medications that are included on WADA’s Prohibited List.
Please click HERE to access WADA’s full article.
Previous ‘Spotlight’ features are available on WADA’s website.